PATENT CLAIM ANALYSIS

Application Number: 15766459
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "186100"]

Abstract:
The invention relates to an anti-cancer vaccine combination. Particularly, the invention relates to a pharmaceutical combination comprising a PD-L1/PD-1 expression inhibitor in combination with a viral antigen-associated vaccine.

Claim (Index 1):
A pharmaceutical combination, comprising an anti-PD-L1 antibody or anti-PD-1 antibody in combination with a HPV antigen-associated vaccine.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 91.0
- Lexical Diversity: 1.40909
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14883557', '14163269', '14789226', '12213696', '15306289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7198213522193283
- 35 USC 102 Novelty (BERT): 0.5440919746940214
- Combined Prediction Score: 0.7022484144667975
- Mean Citation Score: 398.07744
- Max Citation Score: 414.82068
- Similarity Product: 283.6806070255208

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test